Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
. 2021 Oct 6:375:n2288.
doi: 10.1136/bmj.n2288.

Female authorship of covid-19 research in manuscripts submitted to 11 biomedical journals: cross sectional study

Affiliations

Female authorship of covid-19 research in manuscripts submitted to 11 biomedical journals: cross sectional study

Angèle Gayet-Ageron et al. BMJ..

Abstract

Objective: To describe prominent authorship positions held by women and the overall percentage of women co-authoring manuscripts submitted during the covid-19 pandemic compared with the previous two years.

Design: Cross sectional study.

Setting: Nine specialist and two large general medical journals.

Population: Authors of research manuscripts submitted between 1 January 2018 and 31 May 2021.

Main outcome measures: Primary outcome: first author's gender.

Secondary outcomes: last and corresponding authors' gender; number (percentage) of women on authorship byline in "pre-pandemic" period (1 January 2018 to 31 December 2019) and in "covid-19" and "non-covid-19" manuscripts during pandemic.

Results: A total of 63 259 manuscripts were included. The number of female first, last, and corresponding authors respectively were 1313 (37.1%), 996 (27.9%), and 1119 (31.1%) for covid-19 manuscripts (lowest values in Jan-May 2020: 230 (29.4%), 165 (21.1%), and 185 (22.9%)), compared with 8583 (44.9%), 6118 (31.2%), and 7273 (37.3%) for pandemic non-covid-19 manuscripts and 12 724 (46.0%), 8923 (31.4%), and 10 981 (38.9%) for pre-pandemic manuscripts. The adjusted odds ratio of having a female first author in covid-19 manuscripts was <1.00 in all groups (P<0.001) compared with pre-pandemic (lowest in Jan-May 2020: 0.55, 98.75% confidence interval 0.43 to 0.70). The adjusted odds ratio of having a woman as last or corresponding author was significantly lower for covid-19 manuscripts in all time periods (except for the two most recent periods for last author) compared with pre-pandemic (lowest values in Jan-May 2020: 0.74 (0.57 to 0.97) for last and 0.61 (0.49 to 0.77) for corresponding author). The odds ratios for pandemic non-covid-19 manuscripts were not significantly different compared with pre-pandemic manuscripts. The median percentage of female authors on the byline was lower for covid-19 manuscripts (28.6% in Jan-May 2020) compared with pre-pandemic (36.4%) and non-covid-19 pandemic manuscripts (33.3% in Jan-May 2020). Gender disparities in all prominent authorship positions and the proportion of women authors on the byline narrowed in the most recent period (Feb-May 2021) compared with the early pandemic period (Jan-May 2020) and were very similar to values observed for pre-pandemic manuscripts.

Conclusions: Women have been underrepresented as co-authors and in prominent authorship positions in covid-19 research, and this gender disparity needs to be corrected by those involved in academic promotion and awarding of research grants. Women attained some prominent authorship positions equally or more frequently than before the pandemic on non-covid-19 related manuscripts submitted at some time points during the pandemic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the university hospitals of Geneva, Geneva Medical School, and the SNF for the submitted work; SS and MR are full time employees of BMJ Publishing Group but are not involved in decision making on research submissions; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Curves (using smoothing parameter of seven days) of total number of research manuscripts and covid-19 manuscripts submitted per day between 1 January 2018 and 31 May 2021 to 11 participating journals from BMJ Publishing Group
Fig 2
Fig 2
Proportion of female first, last, and corresponding authors across two month periods between 1 January 2018 and 31 May 2021 among covid-19 and non-covid-19 manuscripts submitted to 11 participating journals from BMJ Publishing Group

Comment in

Similar articles

Cited by

References

    1. Filardo G, da Graca B, Sass DM, Pollock BD, Smith EB, Martinez MAM. Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014). BMJ 2016;352:i847. 10.1136/bmj.i847 - DOI - PMC - PubMed
    1. Jagsi R, Guancial EA, Worobey CC, et al. . The “gender gap” in authorship of academic medical literature--a 35-year perspective. N Engl J Med 2006;355:281-7. 10.1056/NEJMsa053910 - DOI - PubMed
    1. Bendels MHK, Müller R, Brueggmann D, Groneberg DA. Gender disparities in high-quality research revealed by Nature Index journals. PLoS One 2018;13:e0189136. 10.1371/journal.pone.0189136 - DOI - PMC - PubMed
    1. Gayet-Ageron A, Poncet A, Perneger T. Comparison of the contributions of female and male authors to medical research in 2000 and 2015: a cross-sectional study. BMJ Open 2019;9:e024436. 10.1136/bmjopen-2018-024436 - DOI - PMC - PubMed
    1. Blasko Z, Papadimitriou E, Manca A. How will the COVID-19 crisis affect existing gender divides in Europe? 2020. https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-res....

Publication types

close